CEL-SCI公司宣布:Multikine获SFDA批准后,Amarox将成为其在沙特阿拉伯的独家商业分销商

美股速递
May 11

CEL-SCI公司宣布,其抗癌药物Multikine在获得沙特阿拉伯食品药品监督管理局(SFDA)批准后,Amarox公司将成为该药物在沙特阿拉伯市场的独家商业分销商。这一合作标志着CEL-SCI在中东地区商业布局的重要一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10